ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Taipei City, TWN:

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Purpose of the study was to assess the effect of enzalutamide on time to Prostate Specific Antigen (PSA) progression as compared to placebo ...

Active, not recruiting
Progressive Metastatic Prostate Cancer
Drug: Enzalutamide
Drug: Placebo

Phase 3

Astellas
Astellas

Taipei, Taiwan and 46 other locations

Locations recently updated

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

Taipei, Taiwan and 48 other locations

therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: Enzalutamide 160 mg
Drug: Olaparib 400 mg

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Taipei, Taiwan and 32 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Taipei, Taiwan and 225 other locations

To evaluate the effect of MCS® compared with placebo in reducing the risk of biopsy-detectable prostate cancer in high-risk subject...

Active, not recruiting
Prostate Cancer
Drug: MCS®
Drug: Placebo

Phase 2

Health Ever Bio-Tech

Taipei, Taiwan

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Taipei, Taiwan and 388 other locations

to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...

Active, not recruiting
Hormone-Sensitive Prostate Cancer
Drug: Capivasertib
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 322 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Enrolling
Prostate Cancer
Drug: docetaxel
Drug: capivasertib

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 249 other locations

in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...

Active, not recruiting
Prostatic Neoplasms
Drug: Bicalutamide Placebo
Radiation: 74-80 Grays (units of radiation)

Phase 3

Aragon Pharmaceuticals

Taipei, Taiwan and 271 other locations

The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...

Active, not recruiting
Metastatic Hormone Sensitive Prostate Cancer
Drug: Placebo
Drug: Enzalutamide

Phase 3

Astellas
Astellas

Taipei, Taiwan and 202 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems